WindRose Health Investors Recapitalizes Veristat Group Inc.
April 7, 2021
WindRose Health Investors completed an equity recapitalization of Veristat Group Inc., a global clinical research organization, with Veristat management retaining a significant minority stake. The investment will provide capital and strategic resources to support Veristat's growth and expansion across clinical development, regulatory affairs, biostatistics, data management and pharmacovigilance; terms were not disclosed.
- Targets
- Veristat Group Inc.
- Sellers
- Variance Development Partners
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Recapitalization
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.